Personalis Inc PSNL:NASDAQ

Last Price$4.81NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/17/22

Today's Change+0.01(0.21%)
Bid (Size)$3.62 (23)
Ask (Size)$6.10 (3)
Day Low / High$4.70 - 5.14
Volume404.3 K
  • Latest Stories
  • Commentary and Analysis
--Citigroup Adjusts Personalis' Price Target to $14 from $18, Keeps Buy Rating
1:21PM ET 5/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--HC Wainwright Adjusts Personalis' Price Target to $30 From $38, Reiterates Buy Rating
7:16AM ET 5/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (PSNL) PERSONALIS Reports Q1 Revenue $15.2M, vs. Street Est of $14.4M
4:05PM ET 5/04/2022 MT Newswires

...

Evaxion Biotech to Use Personalis Platform to Evaluate Efficacy of Skin Cancer Combination Therapy
10:56AM ET 4/26/2022 MT Newswires

Evaxion Biotech (EVAX) will use Personalis's (PSNL) ImmunoID NeXT platform in a phase 2b trial to assess the efficacy and safety of its EVX-01 personalized...

Personalis Awarded US Patent Related to Screening Platform for Minimal Residual Disease and Recurrence in Cancer Patients
10:43AM ET 4/12/2022 MT Newswires

Personalis (PSNL) said Tuesday it has received a US patent related to its NeXT Personal platform used in detecting minimal residual disease and recurrence...

--HC Wainwright Adjusts Personalis Price Target to $38 From $50, Maintains Buy Rating
12:03PM ET 2/25/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Citigroup Adjusts Personalis Price Target to $18 From $30, Maintains Buy Rating
12:03PM ET 2/25/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Oppenheimer Adjusts Personalis' Price Target to $24 From $30, Maintains Outperform Rating
10:24AM ET 2/25/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (PSNL) PERSONALIS Posts Q4 Revenue $20.7M, vs. Street Est of $20.7M
4:08PM ET 2/24/2022 MT Newswires

...

Morgan Stanley Adjusts Personalis Price Target to $14 From $25, Maintains Equalweight Rating
11:02AM ET 2/15/2022 MT Newswires

Personalis (PSNL) has an average rating of outperform and price targets ranging from $14 to $50, according to analysts polled by Capital IQ. (MT Newswires...